David Spellmeyer, Ph.D.
Dr. Spellmeyer is a biotechnology executive with 25 years of broad experience in the life sciences industry. He currently serves as CSO at Circle Pharma, an SPII VC portfolio company and heads Interlaken Associates where he advises early-stage companies and investors on corporate and technical strategy, product development, commercialization, and funding. He previously served as CTO & CIO at Nodality and in research leadership roles at both large and small companies. Dr. Spellmeyer received his BS in computer science and chemistry from Purdue University and his PhD in theoretical organic chemistry from UCLA. He completed postdoctoral training in pharmaceutical chemistry at UCSF, where he is an adjunct Associate Professor.